Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number): Why Should I Register and Submit Results? Please do not continue treatment with an empty medication cup as this can cause irritation. In conjunction with mechanical ventilation, IPV has been shown to improve patients presenting with ARDS. 0000006477 00000 n The MetaNeb System therapy be used in appropriate patients with an indication for airway clearance and/or lung expansion therapy. View Product Details Contact a Respiratory Health representative for more information Call us at (800) 426-4224 or scopic" procedure. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Demographic, clinical & outcome data will be collected for eligible patients during the two stages of the study. 0000027826 00000 n The therapy cycle is about 10 minutes long, with the CPEP and CHFO transition occurring four times during the session. Accept Read More. The study will be conducted in two stages. Patients who may benefit from The MetaNeb System include those with pulmonary atelectasis or secretions associated with the following conditions: *Therapy times may differ depending on patient needs and ordered therapies. Unlike the former, manual approach, oscillation technology affords a more consistent, uniform, and gentle approach to secretion clearance. (2013). 0000028340 00000 n One device. Read full description Request More Information Overview Education & Documentation Overview Subscribe to Medical Design & Outsourcing. Although SARS-CoV is transmitted primarily by contact and/or droplet routes, airborne transmission over a limited distance (e.g., within a room), has been suggested, though not proven.3. You add on top of that the nebulizer and you have that three in one benefit. 495 0 obj <>/Filter/FlateDecode/ID[<1742E9C112FBC5499E861B44C2B66805><4050128B81A18744A2B46EC044BDCEFD>]/Index[472 38]/Info 471 0 R/Length 110/Prev 216860/Root 473 0 R/Size 510/Type/XRef/W[1 3 1]>>stream 0000027320 00000 n endstream endobj 473 0 obj <. outcomes data with the MetaNeb System, the intended use of MetaNeb System therapy is for lung expansion and secretion clearance treatments regardless of etiology. Cytokinetics Enrolls 700 ALS Patients in Phase 3 Study of Tirasemtiv, Praxair Approved to Market Inhaled Nitric Oxide in Canada, aTyr Announces Phase 2 Study of SSc-ILD Drug, Mercks Keytruda Meets Primary Endpoint in Phase 3 Trial for Lung Cancer, Dynarex Accepting Applications for 2023 Scholarship Program, Bacteremia with COVID-19 More Deadly Than Known Risk Factors Like Age and Sex, Toolkit to Support Clinicians in Quicker Diagnosis of ILDs, RT: For Decision Makers in Respiratory Care. Both have shown increased aeration, improvement in ventilation, and mucus clearance in both intubated and non-intubated patients. 0000009831 00000 n While it has been used to treat more than 400 diseases and conditions, it is most commonly used to treat cystic fibrosis, cerebral palsy, quadriplegia conditions, ALS, COPD, and bronchiectasis. hb```B eaq]w,y{9 Y :Y-P%?: - A 2015 study published in Expert Review Respiratory Medicine indicated that PPCs might beset post-surgical patients at ratea as high as 40 percent, emphasizing the benefit of taking a proactive approach. Mellor of Hill-Rom noted that ultimately its a question of finding a provider that offers a quality product and stands behind it. To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Such devices provide both LE and airway clearance therapy (ACT) for patients with obstructive and/or restrictive lung diseases and conditions. Skarvan noted that in these cases it may be used as a preventative treatment to help keep hospital patientsincluding those who will be prone for long periods of timeclear of secretions and possible infections. Instead of introducing a suction catheter into the airway, air is delivered noninvasively through a facemask, a mouthpiece, or a simple adapter that allows the device to function with an endotracheal or tracheostomy tube. With any therapy, the key is to ensure quality of life and so we have uniquely designed our device with a single hose, which helps us accommodate a softer start and an active inflate and deflate. Continue on this for 2 minutes then encourage the patient to cough or huff cough. 0000005870 00000 n CPEP mode provides aerosol combined with continuous positive pressure helping with lung expansion. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. If performing by the mouthpiece, allow the patient to take a break and cough or huff cough. Meanwhile, Electromeds Skarvan advises clinicians to look for a device that fits the patients needs in order to improve their quality of life and reduce the number of their hospital visits. RT, _________________________________________________________________, C.A. Your email address will not be published. Use of The MetaNeb System will follow the labeling of the device. All Rights Reserved. Site Map | Privacy Policy | RSS, Is Medtech really recession proof? IPV promotes mobilization of secretions, provides nebulized therapy, and provides intrathoracic vibration and percussion, thus improving ventilation. doi: Siegel JD, Rhinehart E, Jackson M, Chiarello L, and the Healthcare Infection Control Practices Advisory Committee, 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings, Ferguson, N. M. et. The MetaNeb System is indicated for the mobilization of secretions, lung expansion therapy, the treatment and prevention of pulmonary atelectasis, and has the ability to provide supplemental oxygen when used with compressed oxygen. 2021 Hill-Rom Services PTE Ltd. ALL RIGHTS RESERVED. The MetaNeb System has been shown to treat pneumonia, trauma, post-op, chronic respiratory conditions, and other conditions to improve respiratory status and reduce pulmonary complications. Monitor CSF chemistry, cytology, and physiology. Learn more about MetaNeb System. 0000007907 00000 n Set CPEP 10-30 based on patient tolerance. Unlike IPV, Metaneb allows the clinician to change rotate between the Oscillatory effect (CHFO) and the lung expansion mode (CPEP). Wolski is a contributing writer to RT magazine. (2018). Image from Lei et al. 0000003482 00000 n 0000003127 00000 n Technology changed all that. Copyright 2023 WTWH Media, LLC. 0000027091 00000 n Its really about coaching the patient on the deep breathing piece, explaining that theyre going to get percussedso they know theres some secretion clearance that will be going on. Alternating between the cycles of CPEP and CHFO helps maximize therapy effectiveness when combined with aerosol therapy. https://assets.hillrom.com/is/image/hillrom/MetaNeb_ai0444_0078_shadow?$recentlyViewedProducts$, /en/products/request-more-information/?Product_Inquiry_Type=More%20Information&I_am_most_interested_in=Non-Invasive%20Respiratory%20Therapy&Product_Name=MetaNeb_System, hillrom:care-category/non-invasive-respiratory-therapy, hillrom:sub-category/therapy-oscillation-lung-expansion,hillrom:care-setting/acute-care, https://www.hillrom.com/en/products/the-metaneb-system/#overview-0, https://www.hillrom.com/en/products/the-metaneb-system/#educationdocumentation-1, MetaNeb System Controller close-up, front facing, An older patient in a hospital bed receives therapy from the MetaNeb system, his clinician nearby, A clinician with a gloved hand adjusts a control knob on the MetaNeb System Controller, A clinician with a gloved hand adjusts the MetaNeb Circuit, patient in background, A clinician connects the MetaNeb system to administer therapy to a patient who has been intubated, A clinician with gloved hands connects the MetaNeb system for use with ventilation, A young patient in a hospital bed receives therapy from the MetaNeb system, with help from her clinician, Chronic Obstructive Pulmonary Disease (COPD), Patients who need Post Operative Airway Management, Patients who need Emergency Room Airway Management, Introduces continuous high-frequency oscillation (CHFO) therapy immediately after lungs have been expanded through continuous positive expiratory pressure (CPEP), Integrates aerosol delivery of medications for maximum efficiency. Indications. The device begins by offering continuous positive expiratory pressure (CPEP) therapy, which helps expand the lungs, and then seamlessly moving on to the secretion clearance part of the treatment, which the company refers to as continuous high frequency oscillation (CHFO) therapy, at regular intervals. Complication, Journal of the American College of Surgeons (2019) 2 Restrepo R, Braverman J. And you take time to switch back and forth.. 10 Minutes Total*: Alternating cycles of CPEP and CHFO combined with aerosol delivery helps maximize therapy effectiveness. Critical Care Pulmonologists share their insights on using Oscillation & Lung Expansion (OLE) therapy with ventilated COVID-19 patients. An albuterol dose can be added in conjunction. Huynh TT, Liesching TN, Cereda M, et. 0000024185 00000 n Chest high-frequency oscillatory treatment for severe atelectasis in a patient with toxic epidermal necrolysis. For general information, Learn About Clinical Studies. Webinar: MetaNebSystem OLE Therapy in the COVID-19 Pandemic. Spinal surgery involving a posterior approach Surgery for organ transplant Chronic invasive positive pressure ventilation (PPV). If performing with an artificial airway, deflate the cuff slightly during therapy remembering to re-inflate after therapy is completed. It consists of a pneumatic compressor that delivers OLE therapy using both continuous high-frequency oscillation (CHFO) and continuous positive expiratory pressure (CPEP). A typical patient might be someone with cystic fibrosis, which required hand manipulating and pounding the chest area to break the mucus from the lung wall and allow the patient to expectorate it. Put the master switch in the . 0000008718 00000 n No The MetaNeb System may be used in appropriate patients with an indication for airway clearance and/or lung expansion therapy. The handheld, lightweight, easy-to-clean device has been available for about 1 years for use both clinically and at-home by patients. %PDF-1.6 % Typical self-administered patient treatments consist of two 15- to 30-minute sessions per day. The MetaNeb System has been shown to treat pneumonia, trauma, post-op, chronic respiratory conditions, and other conditions to improve respiratory status and reduce pulmonary complications. The purpose of this prospective randomized clinical trial is to evaluate three different types of hyperinflation respiratory therapies, Intermittent Positive Pr. ACT uses physical or mechanical means to manipulate air flow,tomobilizesecretionscephalad,andtofacilitateevac-uation by coughing.11 Breathing maneuvers, gravity as-sisted drainage, manual techniques, and mechanical de-vices can be used in an effort to facilitate secretion mobilization. The Medical Device Business Journal. Expanded Medicare coverage for CGM to go into effect next month, Bigfoot Biomedical wins FDA clearance for Bigfoot Unity Android app, Vivani Medical wants to bring a subdermal drug delivery implant to the diabetes market, Eli Lilly is cutting the price of insulin by 70%, SonoThera licenses GE HealthCare microbubbles for guided gene therapy delivery, Subscribe to Drug Deliverys E-Newsletter. hb```c````e`jab@ !G#b.S.KusL7X:b6K*}z:q[hG[jAH60mFl&@HGGZdx2+00OdZFUU5Ed83mePp'ຣ@ 3I Please remove one or more studies before adding more. Ultimately, the goal is to drive those secretions out to prevent chronic infections. With the exception of standard airway clearance and lung expansion procedures, other components of the patients respiratory care regimen will remain the same as during the standard therapy period, however the CHANGE IN PRACTICE will incorporate the use/treatment with The MetaNeb System as an alternative to usual airway clearance and lung expansion procedures. endstream endobj startxref Recently presented at the Society of Critical Care Medicine (SCCM) Annual Congress, the research by Toan Huynh, MD, and colleagues specifically considered the incidence of post-operative pulmonary complications (PPCs) in high-risk patients, evaluating the impact of strategically employing aggressive pulmonary utilizing the MetaNeb system. Current challenges in the recognition, prevention and treatment of perioperative pulmonary atelectasis. PEP (EzPAP, MetaNeb) is performed if patient is: Unable to perform IS-or- Not meeting incentive spirometry goal or Has persistent or severe atelectasis or Has poor oxygenation Induced deep breathing in patients with a tracheostomy Indications and frequency in the VEP - the RT will assess patient and assign them a RT Triage Score. Add 20 mL of normal saline or hypertonic saline to the medication cup. Paul, MN 55126, PatientsImportance of Respiratory HealthManage My TherapyProductsPatient Stories, Healthcare ProfessionalsBreak the Vicious CycleManage My PatientsProductsVA Government Options, ResourcesVideo LibraryEducation OptionsReimbursement ServicesInsurance CoverageGlossary of Terms, About UsInnovation MilestonesOur VisionCustomer ServiceIn the NewsEvents, Privacy Policy | Terms of Use | HIPAA Notice of Privacy Practices. A lung-expansion therapy, MetaNeb enhances mucus clearance and helps resolve or fully prevent patchy atelectasis. Attention: Not all products/options are available in all countries. Save my name, email, and website in this browser for the next time I comment. It is designed to maximize treatment by combining three therapies in onevolume expansion, secretion clearance, and nebulizer therapy. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights. Although PPCs are an incompletely understood multifactorial syndrome, atelectasis is recognized as a critical component. Indications would be worsening oxygenation, increasing FIO2 and/or PEEP, evidence of lung collapse or mucus plugging, and/or retained pulmonary secretions in the absence of an effective cough. (2006). (Clinical Trial), Evaluation of a Practice Change to Include The MetaNeb System to Reduce Postoperative Pulmonary Complications, 18 Years and older (Adult, Older Adult), Burlington, Massachusetts, United States, 01805, Charlotte, North Carolina, United States, 28203, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States, 19104, Significant Postoperative Pulmonary Complication Incidence [TimeFrame:Occurs within seven (7) days of the post-surgical admission will be considered a Significant Postoperative Pulmonary Complication], Requirement for invasive mechanical ventilation for > 48 hours within seven (7) days of the post-surgical hospital admission [TimeFrame:from the time of the post-surgical admission to the hospital unit until discharge from the hospital, up to 8 weeks], Requirement for respiratory support > 48 hours within seven (7) days of the post-surgical hospital admission [TimeFrame:from the time of the post-surgical admission to the hospital unit until time of discharge from the hospital, up to 8 weeks], Length of ICU stay during initial hospital stay [TimeFrame:Total days/hours until time of discharge from the hospital, up to 8 weeks], Length of hospital stay during initial hospital stay [TimeFrame:Time of admission until time of discharge from the hospital, up to 8 weeks], Readmission to ICU and transfers to elevated level of care for pulmonary complications during initial hospital stay [TimeFrame:during hospital stay, up to 8 weeks], Readmission to hospital [TimeFrame:30 days following discharge from the hospital], Time on Mechanical Ventilation [TimeFrame:total hours/days from the time of the post-surgical admission to the hospital unit until time of discharge from the hospital, up to 8 weeks]. The 10-minute timeframe isnt arbitrary, since most nebulizer treatments run about that duration, Mellor noted. Select two study versions to compare. Documented ASA class 2 AND One or more of the following: Current smoker or smoking history within past 6 months History of COPD Documented obesity and/or BMI 30 kg/m2 Age 75, Contraindication to Continuous High Frequency Oscillation (CHFO) therapy Minimally invasive, or ".